Evidence was considered from several sources, including a diagnostics assessment report and an overview of that report. Full details are in the project documents for this guidance. A patient expert ...
DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. A sutureless device for peripheral nerve repair could be available on the market in the coming months ...
The U.S. FDA has finalized a guidance for class II devices for treatment of peripheral artery disease that excludes drug-coated balloons (DCBs), which are regulated as class III devices. One of the ...
The US Food and Drug Administration is alerting the public of a potentially high-risk device issue related to Rotarex Atherectomy Systems (Bard Peripheral Vascular) used in peripheral artery ...
Drug-coated stents and balloons were not associated with a reduction in amputations or improved quality of life compared with uncoated devices among patients with peripheral artery disease, according ...
Inserting, monitoring, and maintaining peripheral venous access is an integral component of neonatal nursing care. Although complications associated with peripheral vascular devices are typically ...
The First Relief percutaneous neurostimulation device can be used to treat pain related to diabetic neuropathy. It is applied behind the ear and delivers continuous pulses of a low-level electrical ...
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. A sutureless device for peripheral nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback